Placental expression of angiogenic factors in Trisomy 13

American Journal of Obstetrics and Gynecology

Volumn 204, Issue 6, 2011, Pages 546.e1-546.e4

  Silasi, Michelle ^a   Rana, Sarosh ^a   Powe, Camille ^a   Cohen, Bruce ^a   Lim, Kee Hak ^a   Zsengellr, Zsuzsanna K ^a   Karumanchi, S Ananth ^a,b   Stillman, Isaac E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

angiogenic factors; preeclampsia; soluble fms like tyrosine kinase 1; Trisomy 13

Indexed keywords

ANGIOGENIC FACTOR; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; KRUSKAL WALLIS TEST; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANK SUM TEST; RETROSPECTIVE STUDY; TRISOMY 13; TROPHOBLAST;

EID: 79958091927     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.02.027     Document Type: Article

References (24)

1. J.W. Wladimiroff, P.A. Stewart, A. Reuss, and E.S. Sachs Cardiac and extra-cardiac anomalies as indicators for trisomies 13 and 18: a prenatal ultrasound study Prenat Diagn 9 1989 515 520 (Pubitemid 19194249)
2. A.I. Taylor Autosomal trisomy syndromes: a detailed study of 27 cases of Edwards' syndrome and 27 cases of Patau's syndrome J Med Genet 5 1968 227 252
3. C.D. Lehman, D.A. Nyberg, T.C. Winter 3rd, R.P. Kapur, R.G. Resta, and D.A. Luthy Trisomy 13 syndrome: prenatal US findings in a review of 33 cases Radiology 194 1995 217 222 (Pubitemid 24380956)
4. P.A. Jacobs, T.J. Hassold, A. Henry, D. Pettay, and N. Takaesu Trisomy 13 ascertained in a survey of spontaneous abortions J Med Genet 24 1987 721 724 (Pubitemid 18002273)
5. P.A. Boyd, R.H. Lindenbaum, and C. Redman Pre-eclampsia and trisomy 13: a possible association Lancet 2 1987 425 427
6. C. Bower, F. Stanley, and B.N. Walters Pre-eclampsia and trisomy 13 Lancet 2 1987 1032 (Pubitemid 17150888)
7. J.F. Tuohy, and D.K. James Pre-eclampsia and trisomy 13 Br J Obstet Gynaecol 99 1992 891 894
8. D. Kanter, M.D. Lindheimer, and E. Wang Angiogenic dysfunction in molar pregnancy Am J Obstet Gynecol 202 2010 184 e1-5
9. S.E. Maynard, J.Y. Min, and J. Merchan Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658 (Pubitemid 36278583)
10. R.J. Levine, S.E. Maynard, and C. Qian Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683 (Pubitemid 38364626)
11. R.J. Levine, C. Lam, and C. Qian Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 2006 992 1005 (Pubitemid 44343543)
12. H. Stepan Angiogenic factors and pre-eclampsia: an early marker is needed Clin Sci (Lond) 116 2009 231 232
13. Y. Zhou, M. McMaster, and K. Woo Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome Am J Pathol 160 2002 1405 1423 (Pubitemid 34411644)
14. R. Romero, J.K. Nien, and J. Espinoza A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate J Matern Fetal Neonatal Med 21 2008 9 23
15. O. Erez, R. Romero, and J. Espinoza The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age J Matern Fetal Neonatal Med 21 2008 279 287 (Pubitemid 351652513)
16. A. Wang, S. Rana, and S.A. Karumanchi Preeclampsia: the role of angiogenic factors in its pathogenesis Physiology (Bethesda) 24 2009 147 158
17. J.C. Livingston, R. Chin, B. Haddad, E.T. McKinney, R. Ahokas, and B.M. Sibai Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia Am J Obstet Gynecol 183 2000 1554 1557 (Pubitemid 32061224)
18. Y. Bdolah, G.E. Palomaki, and Y. Yaron Circulating angiogenic proteins in trisomy 13 Am J Obstet Gynecol 194 2006 239 245 (Pubitemid 43017803)
19. A.M. Lachmeijer, G.A. Dekker, G. Pals, J.G. Aarnoudse, L.P. ten Kate, and R. Arngrimsson Searching for preeclampsia genes: the current position Eur J Obstet Gynecol Reprod Biol 105 2002 94 113
20. Bergmann A, Ahmad S, Cudmore M, et al. Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. J Cell Mol Med;14:1857-67.
21. A. Hertig, N. Berkane, and G. Lefevre Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia Clin Chem 50 2004 1702 1703 (Pubitemid 39121252)
22. M. Heydarian, T. McCaffrey, and L. Florea Novel splice variants of sFlt1 are upregulated in preeclampsia Placenta 30 2009 250 255
23. G.C. McKeeman, J.E. Ardill, C.M. Caldwell, A.J. Hunter, and N. McClure Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop Am J Obstet Gynecol 191 2004 1240 1246 (Pubitemid 39421577)
24. V. Tsatsaris, F. Goffin, and C. Munaut Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences J Clin Endocrinol Metab 88 2003 5555 5563 (Pubitemid 37452769)